Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer [NA]
A clinical trial evaluating the ketogenic diet in patients with metastatic pancreatic ductal adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab with the CXCR4 antagonist BL-8040 in metastatic pancreatic cancer has completed, with results poste…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Using Tumor Models to Determine Treatments [Phase 2]
Phase 2 clinical trial at University Health Network uses tumor models to guide treatment choices for pancreatic ductal adenocarcinoma and ot…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma [Phase 1]
Georgetown University reported Phase 1 results for a trial of Eryaspase in combination with a modified FOLFIRINOX regimen in locally advance…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types [Phase 2, Phase 3]
A multicenter validation trial evaluating the PET imaging agent [18F]AlF-FAPI-74 to visualize cancer-associated fibroblasts across esophagea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Advances in Imaging to Assess Response in Pancreatic Cancer (AIR-PANC)
This clinical trial update covers AIR-PANC, an imaging-based study to assess treatment response in pancreatic ductal adenocarcinoma. The stu…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) [Phase 2]
Phase 2 study evaluating two regimens in metastatic pancreatic ductal adenocarcinoma: 5-Fluorouracil with nanoliposomal irinotecan (nal-IRI)…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial ACCENT is evaluating AMP945 in combination with nab-paclitaxel and gemcitabine for pancreatic cancer in Phase 1/2; the study …
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study) [Phase 1, Phase 2]
Phase 1/2 MORNINGSTAR trial evaluating mavrostobart (PT199), an anti-CD73 antibody, alone or with a PD-1 inhibitor or chemotherapy in non-sm…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating a triplet regimen of liposomal irinotecan, S-1, and oxaliplatin in advanced pancreatic cancer (pancre…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC) [Phase 1]
This Phase 1 clinical trial update describes CHASe-PDAC, a study of chemotherapy plus stool transplantation for unresectable or metastatic a…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors [Phase 1]
Phase 1 study of ELI-002 in KRAS-mutated pancreatic ductal adenocarcinoma and other KRAS-driven solid tumors has completed enrollment, with …
-
CLINICAL_TRIALS withdrawal · 2025-01-17Clinical Trial Update: FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma [Phase 1]
A Phase 1 trial of FL118 for pancreatic ductal adenocarcinoma has been withdrawn from the study.
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2 [Phase 3]
Phase 3 trial daNIS-2 evaluating NIS793 in combination with standard-of-care chemotherapy for first-line metastatic pancreatic ductal adenoc…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers [Phase 2]
Phase 2 study evaluating YH003 in combination with toripalimab in patients with melanoma and pancreatic ductal adenocarcinoma has completed.
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of surufatinib and camrelizumab with AS as first-line therapy for advanced metastatic …
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating NLM-001 in combination with standard chemotherapy and Zalifrelimab for advanced pancreatic ductal a…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC [Phase 2]
A Phase 2 clinical trial update evaluating nanoliposomal irinotecan with XELOX plus cadonilimab (AK104) as first-line treatment for advanced…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. [Phase 1]
A Phase I/Ib trial of NZV930 alone and in combination with PDR001 and/or NIR178 in patients with advanced malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
A Phase 2 trial of a combination therapy for untreated metastatic pancreatic ductal adenocarcinoma has completed and posted results.
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature [Phase 3]
Phase 3 adjuvant trial comparing oxaliplatin- versus gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma, with trea…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Study on Single-cell Regulons Atlas of Pancreatic Ductal Adenocarcinoma
A completed clinical trial investigating a single-cell regulons atlas for pancreatic ductal adenocarcinoma to support a molecular prognostic…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: AG Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Locally aPDAC [Phase 2]
Phase 2 clinical trial evaluating AG in combination with Cadonilimab and sequential short-course radiotherapy for locally advanced pancreati…
-
CLINICAL_TRIALS other · 2024-12-04Clinical Trial Update: Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients [Phase 2]
This clinical trial update outlines a Phase 2 study evaluating TTX-030 in combination with chemotherapy, with or without budigalimab, for fi…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating nab-paclitaxel and gemcitabine with or without SBP-101 in metastatic pancreatic ductal adenocarcino…